EP3030251
IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBITOR RESPONSE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
8.8.2014EP published:
24.10.2018EP application number:
14752766.7
EPO information:
European Patent Register
Max expiry date:
7.8.2034
Title:
IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBITOR RESPONSE
Timeline
Today
8.8.2014EP application
24.10.2018EP Publication
Owner
Name:
Onyx Therapeutics, Inc.Address:
One Amgen Center Drive, 91320-1799, Thousand Oaks, CA, US
Inventor
Name:
TUCH, BrianAddress:
Brisbane, CA, US
Name:
DEGENHARDT, JeremiahAddress:
San Mateo, CA, US
Name:
LOEHR, AndreaAddress:
San Francisco, CA, US
Name:
KWEI, KevinAddress:
Mountain View, CA, US
Name:
KIRK, Christopher, J.Address:
San Francisco, CA, US
Priority
Number:
201361863809 PDate:
8.8.2013Country:
US
Number:
201361875954 PDate:
10.9.2013Country:
US
Number:
201462005904 PDate:
30.5.2014Country:
US
Classification
Categories:
A61K 38/05, A61K 38/07, A61K 31/145, A61P 35/02, C12Q 1/68, G01N 33/574